Cargando…

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Van der Perren, Anke, Gelders, Géraldine, Fenyi, Alexis, Bousset, Luc, Brito, Filipa, Peelaerts, Wouter, Van den Haute, Chris, Gentleman, Steve, Melki, Ronald, Baekelandt, Veerle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244622/
https://www.ncbi.nlm.nih.gov/pubmed/32356200
http://dx.doi.org/10.1007/s00401-020-02157-3
_version_ 1783537613704003584
author Van der Perren, Anke
Gelders, Géraldine
Fenyi, Alexis
Bousset, Luc
Brito, Filipa
Peelaerts, Wouter
Van den Haute, Chris
Gentleman, Steve
Melki, Ronald
Baekelandt, Veerle
author_facet Van der Perren, Anke
Gelders, Géraldine
Fenyi, Alexis
Bousset, Luc
Brito, Filipa
Peelaerts, Wouter
Van den Haute, Chris
Gentleman, Steve
Melki, Ronald
Baekelandt, Veerle
author_sort Van der Perren, Anke
collection PubMed
description Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. The recent generation of pure fibrillar αSYN polymorphs with noticeable differences in structural and phenotypic traits has led to the hypothesis that different αSYN strains may be in part responsible for the heterogeneous nature of synucleinopathies. To further characterize distinct αSYN strains in the human brain, and establish a structure-pathology relationship, we pursued a detailed comparison of αSYN assemblies derived from well-stratified patients with distinct synucleinopathies. We exploited the capacity of αSYN aggregates found in the brain of patients suffering from PD, MSA or DLB to seed and template monomeric human αSYN in vitro via a protein misfolding cyclic amplification assay. A careful comparison of the properties of total brain homogenates and pure in vitro amplified αSYN fibrillar assemblies upon inoculation in cells and in the rat brain demonstrates that the intrinsic structure of αSYN fibrils dictates synucleinopathies characteristics. We report that MSA strains show several similarities with PD strains, but are significantly more potent in inducing motor deficits, nigrostriatal neurodegeneration, αSYN pathology, spreading, and inflammation, reflecting the aggressive nature of this disease. In contrast, DLB strains display no or only very modest neuropathological features under our experimental conditions. Collectively, our data demonstrate a specific signature for PD, MSA, and DLB-derived strains that differs from previously described recombinant strains, with MSA strains provoking the most aggressive phenotype and more similarities with PD compared to DLB strains.
format Online
Article
Text
id pubmed-7244622
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72446222020-06-03 The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies Van der Perren, Anke Gelders, Géraldine Fenyi, Alexis Bousset, Luc Brito, Filipa Peelaerts, Wouter Van den Haute, Chris Gentleman, Steve Melki, Ronald Baekelandt, Veerle Acta Neuropathol Original Paper Synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) aggregates throughout the nervous system but diverge from one another with regard to their clinical and pathological phenotype. The recent generation of pure fibrillar αSYN polymorphs with noticeable differences in structural and phenotypic traits has led to the hypothesis that different αSYN strains may be in part responsible for the heterogeneous nature of synucleinopathies. To further characterize distinct αSYN strains in the human brain, and establish a structure-pathology relationship, we pursued a detailed comparison of αSYN assemblies derived from well-stratified patients with distinct synucleinopathies. We exploited the capacity of αSYN aggregates found in the brain of patients suffering from PD, MSA or DLB to seed and template monomeric human αSYN in vitro via a protein misfolding cyclic amplification assay. A careful comparison of the properties of total brain homogenates and pure in vitro amplified αSYN fibrillar assemblies upon inoculation in cells and in the rat brain demonstrates that the intrinsic structure of αSYN fibrils dictates synucleinopathies characteristics. We report that MSA strains show several similarities with PD strains, but are significantly more potent in inducing motor deficits, nigrostriatal neurodegeneration, αSYN pathology, spreading, and inflammation, reflecting the aggressive nature of this disease. In contrast, DLB strains display no or only very modest neuropathological features under our experimental conditions. Collectively, our data demonstrate a specific signature for PD, MSA, and DLB-derived strains that differs from previously described recombinant strains, with MSA strains provoking the most aggressive phenotype and more similarities with PD compared to DLB strains. Springer Berlin Heidelberg 2020-04-30 2020 /pmc/articles/PMC7244622/ /pubmed/32356200 http://dx.doi.org/10.1007/s00401-020-02157-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Van der Perren, Anke
Gelders, Géraldine
Fenyi, Alexis
Bousset, Luc
Brito, Filipa
Peelaerts, Wouter
Van den Haute, Chris
Gentleman, Steve
Melki, Ronald
Baekelandt, Veerle
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title_full The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title_fullStr The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title_full_unstemmed The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title_short The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
title_sort structural differences between patient-derived α-synuclein strains dictate characteristics of parkinson’s disease, multiple system atrophy and dementia with lewy bodies
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244622/
https://www.ncbi.nlm.nih.gov/pubmed/32356200
http://dx.doi.org/10.1007/s00401-020-02157-3
work_keys_str_mv AT vanderperrenanke thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT geldersgeraldine thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT fenyialexis thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT boussetluc thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT britofilipa thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT peelaertswouter thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT vandenhautechris thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT gentlemansteve thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT melkironald thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT baekelandtveerle thestructuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT vanderperrenanke structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT geldersgeraldine structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT fenyialexis structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT boussetluc structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT britofilipa structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT peelaertswouter structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT vandenhautechris structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT gentlemansteve structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT melkironald structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies
AT baekelandtveerle structuraldifferencesbetweenpatientderivedasynucleinstrainsdictatecharacteristicsofparkinsonsdiseasemultiplesystematrophyanddementiawithlewybodies